Medical Device Industry
Filter News
Found 4,903 articles
-
“This is Medidata’s first office in Boston, and the company is excited for the opportunity over the next several years to tap into the amazing life sciences and technology skills that Boston can offer,” said Medidata’s chief people officer.
-
Nevro Files Lawsuit for Patent Infringement Against Stimwave in the U.S.
2/15/2019
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has filed a lawsuit for patent infringement against Stimwave Technologies, Inc.
-
Polarean Imaging plc (AIM: POLX) - New System Order with the University of British Columbia
2/15/2019
Polarean Imaging plc (AIM: POLX), the medical imaging technology company, with a proprietary drug device combination product for the magnetic resonance imaging (MRI) market, announces that it has entered into a contract for the procurement of its latest polarizer system by the University of British Columbia www.ubc.ca (“UBC”) following the conclusion of UBC’s procurement process.
-
Global Medical Device Company Goes Live with Model N Revenue Cloud for MedTech, the Leading Cloud-Based Revenue Management System
2/14/2019
Model N, Inc., the leader in cloud-based revenue management solutions announced that it has partnered with ICU Medical—a worldwide leader in the development, manufacture, and sale of medical devices—to modernize and combine that company’s legacy revenue systems in the cloud with Model N Revenue Cloud for MedTech.
-
FDA issues warning letter to doctor for illegally marketing unapproved device with claims to prevent and treat tightening of scar tissue around breast implants
2/14/2019
Today, the U.S. Food and Drug Administration issued a warning letter to Mark Berman, M.D., of Beverly Hills, California, for illegally marketing an unapproved implantable device, the Pocket Protector, that Dr. Berman claims can prevent and treat a complication of breast implants known as capsular contracture, or tightening of scar tissue.
-
Competitor Analysis Study to Enhance Profitability and Prioritize Areas of Improvement for a Medical Devices Company - A Report by Infiniti Research
2/14/2019
A renowned market intelligence solution provider, Infiniti Research, has recently announced the completion of their latest competitor analysis study for a medical devices company.
-
McGinley Orthopedics Recruits Industry Leader as New CEO
2/14/2019
McGinley Orthopedics, a developer of innovative, patented drill technology that assists surgeons with a goal of changing the standard of care in medicine, has appointed Carl O'Connell as CEO, effective February 4th, 2019.
-
GI Dynamics Announces Institutional Review Board Approval for EndoBarrier Pivotal Trial
2/14/2019
GI Dynamics® Inc., a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce that it has received Institutional Review Board approval to conduct its pivotal trial of EndoBarrier for type 2 diabetes and obesity.
-
CryoLife Reports Fourth Quarter and Full Year 2018 Financial Results
2/14/2019
Total revenues were $67.8 million in the fourth quarter of 2018, reflecting year over year growth of 28% and an 8% increase on a non-GAAP constant currency basis compared to the fourth quarter of 2017
-
diVa By Sciton Receives Approved Indication For The Treatment Of Genitourinary Symptoms Of Menopause (GSM) By Health Canada
2/14/2019
Today, Sciton Inc., a leading manufacturer of medical and aesthetic laser and light source technologies, announced that it has received an expansion of the clearances for their medical device license issued by Health Canada for their diVaⓇ product to include a new indication "for the treatment of the symptoms of Genitourinary Syndrome of Menopause (GSM)" in peri and post-menopausal women.
-
Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth
2/14/2019
Sensus Healthcare, Inc. announces financial results for the three and 12 months ended December 31, 2018.
-
t:slim X2 Insulin Pump First to Receive New ACE Pump Classification by FDA
2/14/2019
Tandem Diabetes Care, Inc. announced that the U.S. Food and Drug Administration has classified the t:slim X2™ insulin pump as the first in a new device category called Alternate Controller Enabled Infusion Pumps.
-
IRRAS AB (Publ) Year-end Report January-December 2018
2/14/2019
During the fourth quarter the company started the launch preparations in the US. Regional sales managers and marketing staff were hired. Contacts were established with hospitals and training of future users of IRRAflow started.
-
Corindus Announces FDA Submission for Neurovascular Intervention Indication for CorPath® GRX Vascular Robotic System
2/14/2019
Expansion of CorPath GRX into neurovascular intervention could mark first step in revolutionizing stroke treatment
-
CONMED Corporation to Present at the SVB Leerink Global Healthcare Conference
2/14/2019
CONMED Corporation announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 10:30 a.m. ET on Thursday, February 28, 2019 in New York, NY.
-
Johnson & Johnson plunked down $3.4 billion in cash to acquire privately held Auris Health, Inc., a company that developed robotic endoscopic technologies that can be used in the treatment of lung cancer.
-
FDA Clears Safe Medical Design’s Innovative New Urinary Catheter Design Aimed At Increased Patient Safety
2/13/2019
Safe Medical Design, Inc. announced that the U.S. Food and Drug Administration cleared the Signal Catheter™ for commercialization in the United States.
-
Life Spine Announces Initiation of SIMPACT® Sacroiliac Joint Fixation Outcomes Study
2/13/2019
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announces the initiation of the SIMPACT Sacroiliac Joint (SI) Fixation Outcomes Study, with Dr. Keith Maxwell of Southeastern Sports Medicine and Orthopedics in Asheville, North Carolina.
-
Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2018
2/13/2019
Provides Update on Enhanced Transformation and Growth Plan, Introduces Full Year 2019 Guidance
-
Titan Medical Reports 2018 Financial Results
2/13/2019
Titan Medical Inc., a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery, announces financial results for the year ended December 31, 2018.